Researchers at the University of California, Irvine have developed a live-imaging system, Phollow, that tracks individual ...

Produced by certain strains of Escherichia coli that reside in the colon and rectum, colibactin is a toxin capable of ...

Universidad Carlos III de Madrid (UC3M) has presented three scientific research projects contributing to the fight against tuberculosis, the leading cause of death from infectious disease in the world ...

A new study has identified a potential new therapy for pulmonary tuberculosis that could shorten the length of treatment and ...

Researchers have developed a chemical probe to study a key component of the Mycobacterium tuberculosis envelope. Their ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...

Tuberculosis (TB) is an infectious disease that kills more than a million people worldwide every year. The pathogen that causes the disease, Mycobacterium tuberculosis, is deadly in part because of ...

Neurology experts from UCSF Health presented new clinical research findings and cutting-edge treatment strategies and received distinguished awards recognition at the American Academy of Neurology’s ...

Scripps Research team offers insights that could aid development of phage therapies against Mycobacteria The pathogens which ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, Johns Hopkins ...

Tuberculosis (TB) is an infectious disease that kills more than a million people worldwide every year. The pathogen that ...